Advances in Functional Magnetic Resonance Imaging: Technology and Clinical Applications

Neurotherapeutics

Volumn 4, Issue 3, 2007, Pages 360-370

  Dickerson, Bradford C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alzheimer's disease; functional magnetic resonance imaging; mild cognitive impairment; plasticity

Indexed keywords

4 AMINOBUTYRIC ACID;

ALZHEIMER DISEASE; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BRAIN FUNCTION; BRAIN INJURY; CEREBROVASCULAR DISEASE; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; DEPTH PERCEPTION; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MENTAL DISEASE; METHODOLOGY; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROIMAGING; NEUROLOGIC DISEASE; NITROGEN AVAILABILITY; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SCINTISCANNING; TASK PERFORMANCE; TIME PERCEPTION;

ALZHEIMER DISEASE; ANIMALS; BRAIN; BRAIN MAPPING; COGNITION DISORDERS; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 34250863313     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2007.05.007     Document Type: Article

References (109)

1. Just M.A., Cherkassky V.L., Keller T.A., Kana R.K., and Minshew N.J. Functional and anatomical cortical underconnectivity in autism: evidence from an FMRI study of an executive function task and corpus callosum morphometry. Cereb Cortex 17 (2007) 951-961
2. Holt D.J., Kunkel L., Weiss A.P., et al. Increased medial temporal lobe activation during the passive viewing of emotional and neutral facial expressions in schizophrenia. Schizophr Res 82 (2006) 153-162
3. Thermenos H.W., Seidman L.J., Poldrack R.A., et al. Elaborative verbal encoding and altered anterior parahippocampal activation in adolescents and young adults at genetic risk for schizophrenia using FMRI. Biol Psychiatry 61 (2007) 564-574
4. Dickerson B.C., and Sperling R.A. Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease. Neurorx 2 (2005) 348-360
5. Burock M.A., Buckner R.L., Woldorff M.G., Rosen B.R., and Dale A.M. Randomized event-related experimental designs allow for extremely rapid presentation rates using functional MRI. Neuroreport 9 (1998) 3735-3739
6. Price C.J., and Friston K.J. Scanning patients with tasks they can perform. Hum Brain Mapp 8 (1999) 102-108
7. Machielsen W.C., Rombouts S.A., Barkhof F., Scheltens P., and Witter M.P. FMRI of visual encoding: reproducibility of activation. Hum Brain Mapp 9 (2000) 156-164
8. Manoach D.S., Halpern E.F., Kramer T.S., et al. Test-retest reliability of a functional MRI working memory paradigm in normal and schizophrenic subjects. Am J Psychiatry 158 (2001) 955-958
9. Sperling R., Greve D., Dale A., et al. Functional MRI detection of pharmacologically induced memory impairment. Proc Natl Acad Sci U S A 99 (2002) 455-460
10. Scheff S.W., Price D.A., Schmitt F.A., and Mufson E.J. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 27 (2006) 1372-1384
11. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 298 (2002) 789-791
12. Coleman P., Federoff H., and Kurlan R. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology 63 (2004) 1155-1162
13. Buckner R.L., Snyder A.Z., Sanders A.L., Raichle M.E., and Morris J.C. Functional brain imaging of young, nondemented, and demented older adults. J Cogn Neurosci 12 suppl 2 (2000) 24-34
14. D'Esposito M., Deouell L.Y., and Gazzaley A. Alterations in the BOLD fMRI signal with ageing and disease: a challenge for neuroimaging. Nat Rev Neurosci 4 (2003) 863-872
15. Grossman M., Koenig P., DeVita C., et al. Neural basis for verb processing in Alzheimer's disease: an fMRI study. Neuropsychology 17 (2003) 658-674
16. Johnson S.C., Saykin A.J., Baxter L.C., et al. The relationship between fMRI activation and cerebral atrophy: comparison of normal aging and Alzheimer disease. Neuroimage 11 (2000) 179-187
17. Saykin A.J., Flashman L.A., Frutiger S.A., et al. Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: patterns of functional MRI activation. J Int Neuropsychol Soc 5 (1999) 377-392
18. Grossman M., Koenig P., Glosser G., et al. Neural basis for semantic memory difficulty in Alzheimer's disease: an fMRI study. Brain 126 (2003) 292-311
19. Thulborn K.R., Martin C., and Voyvodic J.T. Functional MR imaging using a visually guided saccade paradigm for comparing activation patterns in patients with probable Alzheimer's disease and in cognitively able elderly volunteers. AJNR Am J Neuroradiol 21 (2000) 524-531
20. Small S.A., Perera G.M., DeLaPaz R., Mayeux R., and Stern Y. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease. Ann Neurol 45 (1999) 466-472
21. Rombouts S.A., Barkhof F., Veltman D.J., et al. Functional MR imaging in Alzheimer's disease during memory encoding. AJNR Am J Neuroradiol 21 (2000) 1869-1875
22. Kato T., Knopman D., and Liu H. Dissociation of regional activation in mild AD during visual encoding: a functional MRI study. Neurology 57 (2001) 812-816
23. Sperling R.A., Bates J.F., Chua E.F., et al. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry 74 (2003) 44-50
24. Machulda M.M., Ward H.A., Borowski B., et al. Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology 61 (2003) 500-506
25. Celone K.A., Calhoun V.D., Dickerson B.C., et al. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J Neurosci 26 (2006) 10222-10231
26. Rombouts S.A.R.B., Goekoop R., Stam C.J., Barkhof F., and Scheltens P. Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease. Neuroimage 26 (2005) 1078-1085
27. Dickerson B.C., Salat D.H., Bates J.F., et al. Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol 56 (2004) 27-35
28. Dickerson B.C., Salat D.H., Greve D.N., et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 65 (2005) 404-411
29. Hamalainen A., Pihlajamaki M., Tanila H., et al. Increased fMRI responses during encoding in mild cognitive impairment. Neurobiol Aging (2006) September 22, [Epub ahead of print]
30. Sperling R., Chua E., Cocchiarella A., et al. Putting names to faces: successful encoding of associative memories activates the anterior hippocampal formation. Neuroimage 20 (2003) 1400-1410
31. Kircher T., Weis S., Freymann K., et al. Hippocampal activation in MCI patients is necessary for successful memory encoding. J Neurol Neurosurg Psychiatry (2007) February 7, [Epub ahead of print]
32. Rosas H.D., Feigin A.S., and Hersch S.M. Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease. NeuroRx 1 (2004) 263-272
33. Monchi O., Petrides M., Doyon J., Postuma R.B., Worsley K., and Dagher A. Neural bases of set-shifting deficits in Parkinson's disease. J Neurosci 24 (2004) 702-710
34. Johansen-Berg H., Dawes H., Guy C., Smith S.M., Wade D.T., and Matthews P.M. Correlation between motor improvements and altered fMRI activity after rehabilitative therapy. Brain 125 (2002) 2731-2742
35. Carey J.R., Kimberley T.J., Lewis S.M., et al. Analysis of fMRI and finger tracking training in subjects with chronic stroke. Brain 125 (2002) 773-788
36. Reddy H., Narayanan S., Arnoutelis R., et al. Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. Brain 123 (2000) 2314-2320
37. Morgen K., Kadom N., Sawaki L., et al. Training-dependent plasticity in patients with multiple sclerosis. Brain 127 (2004) 2506-2517
38. Buckle G.J. Functional magnetic resonance imaging and multiple sclerosis: the evidence for neuronal plasticity. J Neuroimaging 15 (2005) 82S-93S
39. McAllister T.W., Saykin A.J., Flashman L.A., et al. Brain activation during working memory 1 month after mild traumatic brain injury: a functional MRI study. Neurology 53 (1999) 1300-1308
40. Ernst T., Chang L., Jovicich J., Ames N., and Arnold S. Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology 59 (2002) 1343-1349
41. Desmond J.E., Chen S.H., DeRosa E., Pryor M.R., Pfefferbaum A., and Sullivan E.V. Increased frontocerebellar activation in alcoholics during verbal working memory: an fMRI study. Neuroimage 19 (2003) 1510-1520
42. Callicott J.H., Mattay V.S., Verchinski B.A., Marenco S., Egan M.F., and Weinberger D.R. Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am J Psychiatry 160 (2003) 2209-2215
43. Drummond S.P., Brown G.G., Gillin J.C., Stricker J.L., Wong E.C., and Buxton R.B. Altered brain response to verbal learning following sleep deprivation. Nature 403 (2000) 655-657
44. Cabeza R., Anderson N.D., Locantore J.K., and McIntosh A.R. Aging gracefully: compensatory brain activity in high-performing older adults. Neuroimage 17 (2002) 1394-1402
45. Winterer G., Hariri A.R., Goldman D., and Weinberger D.R. Neuroimaging and human genetics. Int Rev Neurobiol 67 (2005) 325-383
46. Hariri A.R., and Weinberger D.R. Functional neuroimaging of genetic variation in serotonergic neurotransmission. Genes Brain Behav 2 (2003) 341-349
47. Saunders A.M. Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses. J Neuropathol Exp Neurol 59 (2000) 751-758
48. Smith C.D., Andersen A.H., Kryscio R.J., et al. Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease. Neurology 53 (1999) 1391-1396
49. Smith C.D., Andersen A.H., Kryscio R.J., et al. Women at risk for AD show increased parietal activation during a fluency task. Neurology 58 (2002) 1197-1202
50. Bookheimer S.Y., Strojwas M.H., Cohen M.S., et al. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 343 (2000) 450-456
51. Bondi M.W., Houston W.S., Eyler L.T., and Brown G.G. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 64 (2005) 501-508
52. Johnson S.C., Schmitz T.W., Trivedi M.A., et al. The influence of Alzheimer disease family history and apolipoprotein E ε{lunate}4 on mesial temporal lobe activation. J Neurosci 26 (2006) 6069-6076
53. Gron G., Bittner D., Schmitz B., Wunderlich A.P., and Riepe M.W. Subjective memory complaints: objective neural markers in patients with Alzheimer's disease and major depressive disorder. Ann Neurol 51 (2002) 491-498
54. Rombouts S.A., van Swieten J.C., Pijnenburg Y.A., Goekoop R., Barkhof F., and Scheltens P. Loss of frontal fMRI activation in early frontotemporal dementia compared to early AD. Neurology 60 (2003) 1904-1908
55. Miller S., Bates J., Blacker D., Sperling R.A., and Dickerson B.C. Hippocampal activation in MCI predicts subsequent cognitive decline (2006) Presented at the International Conference on Alzheimer's Disease; July 17; Madrid
56. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., and Shulman G.L. A default mode of brain function. Proc Natl Acad Sci U S A 98 (2001) 676-682
57. Lustig C., Snyder A.Z., Bhakta M., et al. Functional deactivations: change with age and dementia of the Alzheimer type. Proc Natl Acad Sci U S A 100 (2003) 14504-14509
58. Greicius M.D., Srivastava G., Reiss A.L., and Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A 101 (2004) 4637-4642
59. Rombouts S.A.R.B., Barkhof F., Goekoop R., Stam C.J., and Scheltens P. Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study. Hum Brain Mapp 26 (2005) 231-239
60. Buckner R.L., Snyder A.Z., Shannon B.J., et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 25 (2005) 7709-7717
61. Ward N.S., and Frackowiak R.S. The functional anatomy of cerebral reorganization after focal brain injury. J Physiol Paris 99 (2006) 425-436
62. Hodics T., Cohen L.G., and Cramer S.C. Functional imaging of intervention effects in stroke motor rehabilitation. Arch Phys Med Rehabil 87 (2006) S36-S42
63. Stinear C.M., Barber P.A., Smale P.R., Coxon J.P., Fleming M.K., and Byblow W.D. Functional potential in chronic stroke patients depends on corticospinal tract integrity. Brain 130 (2007) 170-180
64. McGonigle D.J., Hanninen R., Salenius S., Hari R., Frackowiak R.S., and Frith C.D. Whose arm is it anyway?. An fMRI case study of supernumerary phantom limb. Brain 125 (2002) 1265-1274
65. Maguire E.A., Vargha-Khadem F., and Mishkin M. The effects of bilateral hippocampal damage on fMRI regional activations and interactions during memory retrieval. Brain 124 (2001) 1156-1170
66. Moo L.R., Slotnick S.D., Krauss G., and Hart J. A prospective study of motor recovery following multiple subpial transections. Neuroreport 13 (2002) 665-669
67. Mondadori C.R., Buchmann A., Mustovic H., et al. Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years. Brain 129 (2006) 2908-2922
68. Owen A.M., Coleman M.R., Boly M., Davis M.H., Laureys S., and Pickard J.D. Detecting awareness in the vegetative state. Science 313 (2006) 1402
69. Leslie R.A., and James M.F. Pharmacological magnetic resonance imaging: a new application for functional MRI. Trends Pharmacol Sci 21 (2000) 314-318
70. Honey G., and Bullmore E. Human pharmacological MRI. Trends Pharmacol Sci 25 (2004) 366-374
71. Mattay V.S., Callicott J.H., Bertolino A., et al. Effects of dextroamphetamine on cognitive performance and cortical activation. Neuroimage 12 (2000) 268-275
72. Thiel C.M., Henson R.N., Morris J.S., Friston K.J., and Dolan R.J. Pharmacological modulation of behavioral and neuronal correlates of repetition priming. J Neurosci 21 (2001) 6846-6852
73. Coull J.T., Nobre A.C., and Frith C.D. The noradrenergic alpha2 agonist clonidine modulates behavioural and neuroanatomical correlates of human attentional orienting and alerting. Cereb Cortex 11 (2001) 73-84
74. Goldstein J.M., Jerram M., Poldrack R., et al. Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. J Neurosci 25 (2005) 9309-9316
75. Goekoop R., Barkhof F., Duschek E.J., et al. Raloxifene treatment enhances brain activation during recognition of familiar items: a pharmacological fMRI study in healthy elderly males. Neuropsychopharmacology 31 (2006) 1508-1518
76. Gibbs S.E., and D'Esposito M. Individual capacity differences predict working memory performance and prefrontal activity following dopamine receptor stimulation. Cogn Affect Behav Neurosci 5 (2005) 212-221
77. Breiter H.C., Gollub R.L., Weisskoff R.M., et al. Acute effects of cocaine on human brain activity and emotion. Neuron 19 (1997) 591-611
78. Kalin N.H., Davidson R.J., Irwin W., et al. Functional magnetic resonance imaging studies of emotional processing in normal and depressed patients: effects of venlafaxine. J Clin Psychiatry 58 suppl 16 (1997) 32-39
79. Honey G.D., Bullmore E.T., Soni W., Varatheesan M., Williams S.C., and Sharma T. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc Natl Acad Sci U S A 96 (1999) 13432-13437
80. Mattay V.S., Tessitore A., Callicott J.H., et al. Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 51 (2002) 156-164
81. Fu C.H., Williams S.C., Cleare A.J., et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 61 (2004) 877-889
82. Davidson R.J., Irwin W., Anderle M.J., and Kalin N.H. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 160 (2003) 64-75
83. Bertolino A., Caforio G., Blasi G., et al. Interaction of COMT (Val[108/158]Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia. Am J Psychiatry 161 (2004) 1798-1805
84. Schon K., Atri A., Hasselmo M.E., Tricarico M.D., LoPresti M.L., and Stern C.E. Scopolamine reduces persistent activity related to long-term encoding in the parahippocampal gyrus during delayed matching in humans. J Neurosci 25 (2005) 9112-9123
85. Thiel C.M., Henson R.N., and Dolan R.J. Scopolamine but not lorazepam modulates face repetition priming: a psychopharmacological fMRI study. Neuropsychopharmacology 27 (2002) 282-292
86. Thiel C.M., Bentley P., and Dolan R.J. Effects of cholinergic enhancement on conditioning-related responses in human auditory cortex. Eur J Neurosci 16 (2002) 2199-2206
87. Thiel C.M., Friston K.J., and Dolan R.J. Cholinergic modulation of experience-dependent plasticity in human auditory cortex. Neuron 35 (2002) 567-574
88. Bentley P., Vuilleumier P., Thiel C.M., Driver J., and Dolan R.J. Effects of attention and emotion on repetition priming and their modulation by cholinergic enhancement. J Neurophysiol 90 (2003) 1171-1181
89. Wink A.M., Bernard F., Salvador R., Bullmore E., and Suckling J. Age and cholinergic effects on hemodynamics and functional coherence of human hippocampus. Neurobiol Aging 27 (2006) 1395-1404
90. Rombouts S.A., Barkhof F., Van Meel C.S., and Scheltens P. Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease. J Neurol Neurosurg Psychiatry 73 (2002) 665-671
91. Saykin A.J., Wishart H.A., Rabin L.A., et al. Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain 127 (2004) 1574-1583
92. Goekoop R., Rombouts S.A., Jonker C., et al. Challenging the cholinergic system in mild cognitive impairment: a pharmacological fMRI study. Neuroimage 23 (2004) 1450-1459
93. Goekoop R., Scheltens P., Barkhof F., and Rombouts S.A. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation-a pharmacological fMRI study. Brain 129 (2006) 141-157
94. Thiel C.M. Cholinergic modulation of learning and memory in the human brain as detected with functional neuroimaging. Neurobiol Learn Mem 80 (2003) 234-244
95. Tsukada H., Kakiuchi T., Ando I., Shizuno H., Nakanishi S., and Ouchi Y. Regulation of cerebral blood flow response to somatosensory stimulation through the cholinergic system: a positron emission tomography study in unanesthetized monkeys. Brain Res 749 (1997) 10-17
96. McGaughy J., Koene R.A., Eichenbaum H., and Hasselmo M.E. Cholinergic deafferentation of the entorhinal cortex in rats impairs encoding of novel but not familiar stimuli in a delayed nonmatch-to-sample task. J Neurosci 25 (2005) 10273-10281
97. He Y., Wang L., Zang Y., et al. Regional coherence changes in the early stages of Alzheimer's disease: a combined structural and resting-state functional MRI study. Neuroimage 35 (2007) 488-500
98. Laufs H., Hamandi K., Salek-Haddadi A., Kleinschmidt A.K., Duncan J.S., and Lemieux L. Temporal lobe interictal epileptic discharges affect cerebral activity in "default mode" brain regions. Hum Brain Mapp (2006) Nov 28, [Epub ahead of print]
99. Salek-Haddadi A., Diehl B., Hamandi K., et al. Hemodynamic correlates of epileptiform discharges: an EEG-fMRI study of 63 patients with focal epilepsy. Brain Res 1088 (2006) 148-166
100. Fridman E.A., Hanakawa T., Chung M., Hummel F., Leiguarda R.C., and Cohen L.G. Reorganization of the human ipsilesional premotor cortex after stroke. Brain 127 (2004) 747-758
101. Katscher U., and Bönert P. Parellel magnetic resonance imaging. Neurotherapeutics 4 (2007) 498-509
102. Lutcke H., Merboldt K.D., and Frahm J. The cost of parallel imaging in functional MRI of the human brain. Magn Reson Imaging 24 (2006) 1-5
103. Wiggins G.C., Triantafyllou C., Potthast A., Reykowski A., Nittka M., and Wald L.L. 32-channel 3 Tesla receive-only phased-array head coil with soccer-ball element geometry. Magn Reson Med 56 (2006) 216-223
104. Kahn I., Wiggins C.J., Wiggins G.C., et al. High-resolution 3T and 7T functional MRI: feasibility and specificity (2006) Presented at the Society for Neuroscience; October 14; Atlanta
105. Dickerson B.C., Wright C.I., Miller S., et al. Ultrahigh-field differentiation of medial temporal lobe function: sub-millimeter fMRI of amygdala and hippocampal activation at 7 Tesla (2006) Presented at the Organization for Human Brain Mapping; June 12; Florence
106. Miller K.L., Smith S.M., Jezzard P., and Pauly J.M. High-resolution FMRI at 1.5 T using balanced SSFP. Magn Reson Med 55 (2006) 161-170
107. Dickerson BC, Miller S, Greve DN, et al. Prefrontal-hippocampal-fusiform activity during encoding predicts intra-individual differences in free recall ability: An event-related functional-anatomic MRI study. Hippocampus; (in press).
108. Cramer S.C., and Crafton K.R. Somatotopy and movement representation sites following cortical stroke. Exp Brain Res 168 (2006) 25-32
109. Dickerson B.C., Bakkour A., Salat D.H., et al. The cortical signature of Alzheimer's disease (AD): a high-throughput in vivo MRI-based quantitative biomarker (2007) Presented at the 20th Annual Massachusetts Alzheimer's Disease Research Center Symposium; January 11; Boston